ArticleThe Pan African medical journal2025
Retrospective study of 35 cases of breast cancer associated with pregnancy at the Monastir Maternity and Neonatology Center.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnancy-associated breast cancer (PABC) is a rare and complex condition, posing significant diagnostic and therapeutic challenges, particularly in resource-limited settings such as Tunisia. This study aims to analyze the clinical and therapeutic characteristics of PABC in a Tunisian population to tailor management strategies. We conducted a single-center, retrospective descriptive study of 35 patients diagnosed between January 2004 and December 2023 at the Monastir Maternity and Neonatology Center. Clinical, radiological, histopathological, and prognostic data were collected and analyzed. The incidence of pregnancy-associated breast cancer was 4.8%. The mean age of patients was 35.3 years, with an average delay of 141 days between symptom onset and consultation. Most cancers were non-metastatic, primarily invasive ductal carcinomas. Management included surgery, chemotherapy, and radiotherapy. Recurrence and mortality rates were 22.9% and 17.1%, respectively. The average overall survival was estimated at 106 months, with better prognosis for younger patients without lymph node involvement. This study emphasizes the importance of increased awareness and improved access to care for these patients, as well as the need to strengthen screening and treatment protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.